4D Molecular Therapeutics Inc FDMT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
25.34UNCH (UNCH)
Volume
14,680,700
Close
25.34quote price arrow down-0.30 (-1.17%)
Volume
438,647
52 week range
9.44 - 36.25
Loading...
  • Open25.72
  • Day High25.72
  • Day Low24.36
  • Prev Close25.64
  • 52 Week High36.25
  • 52 Week High Date03/27/24
  • 52 Week Low9.44
  • 52 Week Low Date10/17/23

Key Stats

  • Market Cap1.31B
  • Shares Out51.70M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.89
  • YTD % Change25.07

KEY STATS

  • Open25.72
  • Day High25.72
  • Day Low24.36
  • Prev Close25.64
  • 52 Week High36.25
  • 52 Week High Date03/27/24
  • 52 Week Low9.44
  • 52 Week Low Date10/17/23
  • Market Cap1.31B
  • Shares Out51.70M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.89
  • YTD % Change25.07

RATIOS/PROFITABILITY

  • EPS (TTM)-2.36
  • P/E (TTM)-10.75
  • Fwd P/E (NTM)-8.24
  • EBITDA (TTM)-116.326M
  • ROE (TTM)-25.53%
  • Revenue (TTM)20.453M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-511.20%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On 4D Molecular Therapeutics Inc

 

Profile

MORE
4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat diseases in ophthalmology and pulmonology. The Company has a portfolio of genetic medicine product candidates, with five product candidates in clinical trials in seven patient populations: 4D-150 for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME), 4D-710 for the treatment of cystic...
John Milligan Ph.D.
Executive Chairman of the Board
David Kirn M.D.
Chief Executive Officer, Co-Founder, Director
Fariborz Kamal Ph.D.
President, Chief Operating Officer
Uneek Mehra
Chief Financial and Business Officer
Address
5858 Horton Street #455, Emeryville
Emeryville, CA
94608
United States

Top Peers

SYMBOLLASTCHG%CHG
AKRO
Akero Therapeutics Inc
19.92-0.81-3.91%
TARS
Tarsus Pharmaceuticals Inc
38.24-0.34-0.88%
BLTE
Belite Bio Inc
44.95+2.57+6.05%
MORF
Morphic Holding Inc
29.23-3.22-9.92%
SYRE
Spyre Therapeutics Inc
37.80UNCHUNCH